+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Devices Market by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, Therapeutic Devices), Operation Type (Invasive Devices, Non-Invasive Devices), Access Type, Application, End User - Global Forecast 2025-2030- Product Image
Cardiovascular Devices Market by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, Therapeutic Devices), Operation Type (Invasive Devices, Non-Invasive Devices), Access Type, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Cardiovascular Devices Market by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, Therapeutic Devices), Operation Type (Invasive Devices, Non-Invasive Devices), Access Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336858
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiovascular Devices Market grew from USD 59.21 billion in 2024 to USD 63.77 billion in 2025. It is expected to continue growing at a CAGR of 7.82%, reaching USD 93.04 billion by 2030.

The field of cardiovascular devices is increasingly at the forefront of medical innovation and patient care, fundamentally altering how cardiac conditions are diagnosed, treated, and managed. In this detailed analysis, we explore the current market dynamics, uncover the unique drivers of change, and provide a comprehensive perspective on the evolving competitive landscape. Against the backdrop of a complex regulatory framework and heightened global demand for minimally invasive and high-precision technologies, stakeholders are compelled to re-evaluate traditional approaches. This introductory exploration delves into the robust trend shifts in digital health, rapid technological integration, and the impactful rise of data-driven decision making, underscoring their role in reshaping industry norms. The insights provided here set the stage for a deeper investigation that not only charts the evolution of diagnostic, surgical, and therapeutic solutions but also emphasizes the strategic imperatives integral to fostering sustainable growth in the cardiovascular space. In the ensuing sections, we break down this intricate market into distinct segments, regional nuances, and key player strategies that together form a cohesive narrative designed for industry experts, decision-makers, and investors alike.

Transformative Shifts in the Landscape

In recent years, the cardiovascular device market has undergone transformative shifts that have redefined product development and clinical application. Rapid advancements in digital technology have enabled more accurate patient monitoring and streamlined diagnostic processes. These innovations, including integration with artificial intelligence and advanced imaging modalities, have shifted the focus from reactive care to proactive health management. The convergence of data analytics with real-time monitoring is driving a significant transition in how devices are developed, implemented, and improved over their life cycles. Additionally, broader trends such as personalized medicine, telehealth initiatives, and remote monitoring have catalyzed a series of technological evolutions. Providers are increasingly leveraging these modern capabilities to deliver more precise, minimally invasive interventions that not only reduce recovery times but also improve overall patient outcomes. In essence, the market is evolving from a traditional, treatment-centric approach to one that emphasizes continuous improvement, risk mitigation, and enhanced patient-centric care. This paradigm shift reflects both the ingenuity of recent technological achievements and the adaptability of industry players who are navigating this dynamic space.

Key Segmentation Insights

Detailed segmentation provides an enriched perspective on the structure and breadth of the cardiovascular devices market. The analysis examines device types through a comprehensive lens, breaking them down into Diagnostic & Monitoring Devices, Surgical Devices, and Therapeutic Devices. Within the realm of Diagnostic & Monitoring Devices, technologies such as ECG Systems, Electrode Leads & Accessories, Event Monitors, Holter Monitors, and Implantable Loop Recorders are highlighted. Meanwhile, the Surgical Devices segment is characterized by components that include Cardiac Stents, Catheters, Heart Valves, and Vascular Grafts. The Therapeutic Devices space further encompasses critical tools like Blood Pressure Monitors, Defibrillators, and Pacemakers that are instrumental in treatment protocols.

Segmentation is also carried out based on operation type, where innovations in both Invasive Devices and Non-Invasive Devices present diverse clinical applications. A further dimension is added with access type, distinguishing between Transcutaneous and Transvenous devices, each with its own set of distinct benefits and clinical scenarios. Moreover, the application segment segments the market by specific therapeutic areas such as Cardiac Rhythm Management, Coronary Artery Disease, Peripheral Vascular Disease, and Stroke Management, which underscores the precision with which technologies are now targeted. Lastly, understanding the market through the lens of end users - including Ambulatory Surgical Centers, Home Care, and Hospitals & Clinics - provides an operational perspective that highlights market distribution channels and usage patterns across different healthcare settings. Together, these segmentation insights offer a granular understanding of the market’s structure, facilitating targeted strategies and decision-making processes.

Based on Device Type, market is studied across Diagnostic & Monitoring Devices, Surgical Devices, and Therapeutic Devices. The Diagnostic & Monitoring Devices is further studied across ECG Systems, Electrode Leads & Accessories, Event Monitors, Holter Monitors, and Implantable Loop Recorders. The Surgical Devices is further studied across Cardiac Stents, Catheters, Heart Valves, and Vascular Grafts. The Therapeutic Devices is further studied across Blood Pressure Monitors, Defibrillators, and Pacemakers.

Based on Operation Type, market is studied across Invasive Devices and Non-Invasive Devices.

Based on Access Type, market is studied across Transcutaneous and Transvenous.

Based on Application, market is studied across Cardiac Rhythm Management, Coronary Artery Disease, Peripheral Vascular Disease, and Stroke Management.

Based on End User, market is studied across Ambulatory Surgical Centers, Home Care, and Hospitals & Clinics.

Key Regional Insights

A regional analysis reveals critical drivers shaping market demand and growth trajectories across various geographies. In the Americas, a combination of high healthcare expenditure, widespread adoption of advanced medical technologies, and robust infrastructure positions the market for sustained expansion. The region also benefits from a strong regulatory environment that fosters innovation while ensuring patient safety. In Europe, the Middle East, and Africa, there is an observable trend towards strategic modernization of healthcare systems. These areas are witnessing gradual shifts in market preferences, driven by emerging investments in state-of-the-art healthcare facilities and improved regulatory frameworks that encourage the adoption of innovative cardiovascular technologies. The Asia-Pacific region presents one of the most dynamic growth opportunities, driven by rapid urbanization, increasing healthcare awareness, and substantial investments in research and development. This region not only demonstrates a growing appetite for high-quality cardiovascular care but also highlights an increasing integration of advanced diagnostic and treatment technologies. Each of these geographic areas contributes uniquely to the overall demand dynamics, creating a diverse yet interconnected market landscape ripe with opportunity for technology advancements and clinical innovation.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

The market is defined by a mix of established multinational corporations and emerging innovators that are pushing the boundaries of cardiovascular care. Several leading companies serve as trendsetters, driving both technology adoption and strategic market expansion. Notable players such as Abbott Laboratories, ACS Diagnostics, and Alivecor, Inc. stand out for their commitment to innovation and clinical excellence. In addition, organizations like Asahi Kasei Corporation and B. Braun SE continue to deliver a broad range of devices that address both diagnostic and operative needs. The portfolio of companies further extends to include Baxter International Inc., Bexen Medical, and Biotronik SE & Co KG, whose advancements in device engineering and clinical applications have enhanced market competitiveness. Industry giants such as Boston Scientific Corporation, BPL Medical Technologies Private Limited, and Edwards Lifesciences Corporation have set benchmarks in quality and performance. GE Healthcare, HeartFlow Holding, Inc., and Johnson & Johnson Services, Inc. bolster their market presence by integrating digital solutions with advanced clinical features. Renowned brands like Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, and Medtronic PLC are recognized for their ongoing contributions towards clinical improvements, paralleled by the efforts of Microport Scientific Corporation, Nihon Kohden Corporation, Schiller AG, Siemens Healthineers, Terumo Cardiovascular Systems Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation. The strategic initiatives undertaken by these companies, ranging from mergers and acquisitions to proactive R&D investments, highlight the competitive spirit propelling the sector forward.

The report delves into recent significant developments in the Cardiovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Bexen Medical, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, Edwards Lifesciences Corporation, GE Healthcare, HeartFlow Holding, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co.,Ltd., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Schiller AG, Siemens Healthineers, Terumo Cardiovascular Systems Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation.

Actionable Recommendations for Industry Leaders

For industry leaders aiming to harness the opportunities presented by the evolving cardiovascular device market, it is imperative to adopt a multifaceted approach driven by innovation and strategic growth. Leaders should prioritize the integration of emerging digital platforms that facilitate remote monitoring, data analytics, and AI-enhanced diagnostics, thereby improving patient outcomes while reducing procedural risks. Strategic partnerships and collaborations are essential for pooling expertise, accessing new markets, and accelerating product development cycles. Investment in research and development should be amplified to explore emerging concepts around minimally invasive and patient-specific therapeutic devices. Moreover, adapting agile business models that allow for rapid response to regulatory changes and fluctuating market demands is a crucial component in maintaining competitive advantages. A balanced focus on both product innovation and market expansion will ensure that companies remain at the cutting edge, prepared to address the increasing complexities of cardiovascular disease management. Leaders should also continuously invest in talent and technology infrastructures, ensuring alignment with global best practices and driving sustained growth in an environment characterized by rapid technological change.

In summary, the cardiovascular device market is undergoing substantial transformation characterized by rapid technological advancements and evolving clinical needs. With a detailed segmentation analysis underlying market dynamics, the industry is witnessing innovations across diagnostic, surgical, and therapeutic domains. Regional forecasts further emphasize the potential for growth driven by robust healthcare investments and regulatory advancements. At the intersection of technology and patient-centric care, industry leaders are challenged to navigate complex changes while leveraging strategic partnerships, agile operational models, and robust R&D initiatives. This comprehensive analysis underscores the dynamic interplay between evolving market segments and the accelerating pace of innovation, outlining a clear pathway for stakeholders to secure a competitive edge in the future of cardiovascular care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cardiovascular diseases among population
5.1.1.2. Expanding healthcare infrastructure across the globe
5.1.2. Restraints
5.1.2.1. Issues over cardiovascular devices recall incidences
5.1.3. Opportunities
5.1.3.1. Growing adoption of cardiovascular devices in home healthcare
5.1.3.2. Government initiatives and funding in boosting the adoption of cardiovascular devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for device approval processes
5.2. Market Segmentation Analysis
5.2.1. Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension
5.2.2. End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cardiovascular Devices Market, by Device Type
6.1. Introduction
6.2. Diagnostic & Monitoring Devices
6.2.1. ECG Systems
6.2.2. Electrode Leads & Accessories
6.2.3. Event Monitors
6.2.4. Holter Monitors
6.2.5. Implantable Loop Recorders
6.3. Surgical Devices
6.3.1. Cardiac Stents
6.3.2. Catheters
6.3.3. Heart Valves
6.3.4. Vascular Grafts
6.4. Therapeutic Devices
6.4.1. Blood Pressure Monitors
6.4.2. Defibrillators
6.4.3. Pacemakers
7. Cardiovascular Devices Market, by Operation Type
7.1. Introduction
7.2. Invasive Devices
7.3. Non-Invasive Devices
8. Cardiovascular Devices Market, by Access Type
8.1. Introduction
8.2. Transcutaneous
8.3. Transvenous
9. Cardiovascular Devices Market, by Application
9.1. Introduction
9.2. Cardiac Rhythm Management
9.3. Coronary Artery Disease
9.4. Peripheral Vascular Disease
9.5. Stroke Management
10. Cardiovascular Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Home Care
10.4. Hospitals & Clinics
11. Americas Cardiovascular Devices Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cardiovascular Devices Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Cardiovascular Devices Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Scenario Analysis
14.3.1. DocGo and SHL Telemedicine's SmartHeart Enhances Cardiac Care Nationwide
14.3.2. Philips unveils AI-driven cardiology innovations at TCT 2024 to enhance patient care and clinical workflows
14.3.3. Tentamus Group strengthens global foothold in cardiovascular devices with acquisition of CardioMed Consultants
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CARDIOVASCULAR DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CARDIOVASCULAR DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
FIGURE 4. CARDIOVASCULAR DEVICES MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 19. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 21. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 27. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CARDIOVASCULAR DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ECG SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTRODE LEADS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY EVENT MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE LOOP RECORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY NON-INVASIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STROKE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 68. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 69. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 70. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 109. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 110. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 111. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 112. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 113. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 114. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 118. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 119. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 120. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 121. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 122. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 133. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 134. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 135. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 136. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 137. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 138. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 181. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 182. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 183. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 184. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 185. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 186. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 207. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 208. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 209. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 210. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 211. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 215. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 216. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 217. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 223. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 224. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 225. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 226. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 227. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 231. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 233. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 234. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 235. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 239. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 240. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 241. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 242. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 243. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 254. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 255. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 256. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 257. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 258. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 259. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 279. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 280. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 281. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 283. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 287. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 288. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 289. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 290. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 291. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 295. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 296. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 297. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 298. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 299. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 326. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 327. SPAIN CARDIOVASCULAR DEVICES M

Companies Mentioned

  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Bexen Medical
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Siemens Healthineers
  • Terumo Cardiovascular Systems Corporation
  • Tricog Health
  • Vesalius Cardiovascular Inc.
  • Zoll Medical Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 63.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 93.04 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

United States Cardiovascular Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

United States Cardiovascular Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 125 Pages
  • United States
From
Cardiovascular Devices - Global Strategic Business Report - Product Image

Cardiovascular Devices - Global Strategic Business Report

  • Report
  • 311 Pages
  • Global
From
Cardiovascular Surgery Devices Market by Product Type, Procedure Type, End User - Global Forecast 2025-2030 - Product Image

Cardiovascular Surgery Devices Market by Product Type, Procedure Type, End User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Cardiovascular Anastomosis Devices Market by Product Type, End-Use - Global Forecast 2025-2030 - Product Image

Cardiovascular Anastomosis Devices Market by Product Type, End-Use - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region (Europe. APAC, MEA), And Segment Forecasts, 2025 - 2030 - Product Image

Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region (Europe. APAC, MEA), And Segment Forecasts, 2025 - 2030

  • Report
  • 240 Pages
  • Global
From

About the Cardiovascular Devices Market

The Cardiovascular Devices market is a segment of the medical device industry that focuses on the diagnosis, treatment, and prevention of cardiovascular diseases. It includes a range of products such as pacemakers, stents, catheters, and other implantable devices. These devices are used to diagnose and treat conditions such as arrhythmia, heart failure, and coronary artery disease. The market is driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Additionally, the rising geriatric population and the increasing awareness of cardiovascular diseases are expected to drive the market growth. Some of the major companies in the Cardiovascular Devices market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, St. Jude Medical, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.